NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT04087902 2026-05-20Long-Term Longitudinal QoL in Patients Undergoing EEAOhio State UniversityActive not recruiting400 enrolled